Skip to main content
. 2017 May 3;7:1416. doi: 10.1038/s41598-017-01641-3

Figure 4.

Figure 4

HAND2/TBX5 interaction drastically inhibited by Thalidomide. Protein-protein docking interface between TBX5 and HAND2 modeled DNA binding domain as retrieved from PDB. Only Residues of TBX5 within 5 angstroms of this interaction are shown (A). Those in red are associated with both TBX5-DNA and TBX5-HAND2 interaction from modeling simulation, which shows the position of thalidomide in the context of predicted TBX5-HAND2 interaction (B): TBX5 (cyan) and HAND2 (magenta). The physical interaction between both proteins was assessed by co-immunoprecipitation in the presence or absence (−) of either 4 µM thalidomide or DMSO (C). Ten times the quantity of proteins loaded for western blot was used for immunoprecipitation. Nuclear lysates of both HAND2 and TBX5 were immunoprecipitated with anti‐HA antibody and HAND2 proteins were visualized by western blot with and anti‐flag antibody. Membrane stripping and subsequent western blot analysis was performed with anti‐HA antibody in order to detect TBX5 proteins. Quantitation of the bands showed more than 80% decrease in the interaction when the extracts were incubated in the presence of Thalidomide. (Ctr: control, WB: immunoblot, IP: immnuoprecipitation).